Daily FNArena News

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea regards Cochlear

Nanosonics’ June quarter update proved a positive surprise but most brokers cannot get past the many risks, also finding the shares look expensive

Micro-cap biotech Orthocell is aiming to emulate the successful growth story of Polynovo, nowadays capitalised at $1.1bn

Michael Gable of Fairmont Equities suggests a short term recovery is likely on Wall Street but it’s too early to conclude a bottom has been seen

While 12-month target prices for Coronado Global Resources are set lower following second quarter results, buoyant met coal fundamentals and prices keep brokers Buy-rated

Ahead of the Herd’s Rick Mills highlights the rush of global EV/battery makers to secure materials directly from miners, including Australian-listed miners

Alphinity Investment Management has identified two companies (one ASX-listed) that should outperform during testing times

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. JP Morgan expects Integral Diagnostics has a tough couple of years ahead

Following above-consensus preliminary FY22 results for JB Hi-Fi, some brokers remain concerned by a looming consumer spending slowdown

The Chartist reports that while some caution is required in the short term, the longer term trend for oil is up